Article

Virtual screening for compounds that mimic protein-protein interface epitopes.

Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH), Institute of Pharmaceutical Sciences, Wolfgang-Pauli-Str. 10, CH-8093 Zurich, Switzerland.
Journal of Computational Chemistry (impact factor: 4.58). 12/2011; 33(5):573-9. DOI:10.1002/jcc.22894 pp.573-9
Source: PubMed

ABSTRACT Modulation of protein-protein interactions (PPI) has emerged as a new concept in rational drug design. Here, we present a computational protocol for identifying potential PPI inhibitors. Relevant regions of interfaces (epitopes) are predicted for three-dimensional protein models and serve as queries for virtual compound screening. We present a computational screening protocol that incorporates two different pharmacophore models. One model is based on the mathematical concept of autocorrelation vectors and the other utilizes fuzzy labeled graphs. In a proof-of-concept study, we were able to identify serine protease inhibitors using a predicted trypsin epitope as query. Our virtual screening framework may be suited for rapid identification of PPI inhibitors and suggesting bioactive tool compounds.

0 0
 · 
0 Bookmarks
 · 
38 Views

Keywords

autocorrelation vectors
 
bioactive tool compounds
 
computational protocol
 
computational screening protocol
 
incorporates two different pharmacophore models
 
mathematical concept
 
new concept
 
potential PPI inhibitors
 
PPI
 
PPI inhibitors
 
predicted trypsin epitope
 
proof-of-concept study
 
rapid identification
 
Relevant regions
 
three-dimensional protein models
 
utilizes fuzzy
 
virtual compound screening
 
virtual screening framework
 

Tim Geppert